ACCESSION: MSBNK-SMB_Measured-HSA014P0174002
RECORD_TITLE: Annotated; N-Acetyl-L-aspartic acid; LC-ESI-QFT; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'EL14-neg_1424': {'bp': 360134.0, 'sum': 1264974.0}, 'EL17-neg_1421': {'bp': 307123.0, 'sum': 1138599.0}, 'EL13-neg_1425': {'bp': 295226.0, 'sum': 1037963.0}, 'EL04-neg_1421': {'bp': 279795.0, 'sum': 1094092.0}, 'EL22-neg_1432': {'bp': 238766.0, 'sum': 1002681.0}, 'EL19-neg_1426': {'bp': 218046.0, 'sum': 796522.0}, 'EL20-neg_1428': {'bp': 203874.0, 'sum': 774522.0}, 'EL23-neg_1426': {'bp': 173737.0, 'sum': 689021.0}, 'EL03-neg_1422': {'bp': 173092.0, 'sum': 631513.0}, 'EL21-neg_1421': {'bp': 161085.0, 'sum': 691429.0}, 'EL09-neg_1425': {'bp': 155954.0, 'sum': 627072.0}, 'EL08-neg_1421': {'bp': 152176.0, 'sum': 655256.0}}
COMMENT: RETENTION_TIME_STDEV 0.004
COMMENT: PRECURSOR_M/Z_RAW 174.039838
COMMENT: PRECURSOR_M/Z_STDEV 0.000064
COMMENT: PRECURSOR_IN_MS1 mz 174.040214; int 33.975; delta(ppm) 3.265045
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 3.331; C6H9NO5; [M-H]1; delta(ppm) -3.330525
COMMENT: PROPOSED_MF MS-FINDER 3.355; C6H9NO5; [M-H]-; delta(ppm) -3.349632
COMMENT: PROPOSED_MF SIRIUS5_Sirius 47.015; C6H9NO5; [M-H]-; delta(ppm) -3.349632
COMMENT: PROPOSED_MF SIRIUS5_Sirius 13.828; C7H5N5O; [M-H]-; delta(ppm) -11.034033
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.368; C7H13NS2; [M-H]-; delta(ppm) -8.342774
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.697; C10H9NS; [M-H]-; delta(ppm) 11.027098
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H9NO5; [M-H]-; delta(ppm) -3.349632
COMMENT: PROPOSED_MF SIRIUS6_Sirius 72.158; C6H9NO5; [M-H]-; delta(ppm) -3.349632
COMMENT: PROPOSED_MF SIRIUS6_Sirius 69.447; C4H7N4O4; [M-H]-; delta(ppm) 4.365050
COMMENT: PROPOSED_MF SIRIUS6_Sirius 57.989; C4H8F3NO3; [M-H]-; delta(ppm) 10.700534
COMMENT: PROPOSED_MF SIRIUS6_Sirius 45.922; C5H13NO2Si2; [M-H]-; delta(ppm) -268693.586270
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.936; C7H5N5O; [M-H]-; delta(ppm) -11.034033
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.161; C7H10FNOS; [M-H]-; delta(ppm) 4.461538
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.108; C6H13NOSSi; [M-H]-; delta(ppm) -268694.288053
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.725; C12H5BO; [M-H]-; delta(ppm) 61047.657382
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.368; C7H13NS2; [M-H]-; delta(ppm) -8.342774
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.697; C10H9NS; [M-H]-; delta(ppm) 11.027098
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H9NO5; [M-H]-; delta(ppm) -3.349632
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 19.000; OTCCIMWXFLJLIA-BYPYZUCNSA-N; C6H9NO5; N-Acetyl-L-aspartic acid - 40.0 eV
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; OTCCIMWXFLJLIA-UHFFFAOYSA-N; C6H9NO5; Massbank:PR100851 N-Acetyl-DL-aspartic acidAc-AspNAAN-Acetyl-aspartateN-Acetylaspartate2-acetamidobutanedioic acid
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.053; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; CC(=O)N[C@@H](CC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.890; GIFXBNNGHVCVMF-UHFFFAOYSA-N; [M-H]-; CC1(OC(=O)CC(C(=O)O1)N)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.835; RSYBGFZORPFBEV-SEFKMRKONA-N; [M-H]-; N[C@@H]([C@@H](O)C(=C)C(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.782; SPJCNQDVYQSGSB-UHFFFAOYNA-N; [M-H]-; OCC(=N)C1OC(=O)C(O)C1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.762; AZKKNWAHCAZDCU-UHFFFAOYNA-N; [M-H]-; CC(NC(=O)CC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.727; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; N-Acetyl-L-aspartic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.363; ADZLWSMFHHHOBV-BYPYZUCNSA-N; [M-H]-; N-Formyl-L-glutamic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.154; HXWZRYKURKEOSO-UHFFFAOYNA-N; [M-H]-; 2-Amino-3-oxoadipate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.128; GIFXBNNGHVCVMF-UHFFFAOYSA-N; [M-H]-; 5-amino-2-hydroxy-2-methyl-1,3-dioxepane-4,7-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.101; BNJOZDZCRHCODO-UHFFFAOYSA-N; [M-H]-; dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.095; AZKKNWAHCAZDCU-UHFFFAOYNA-N; [M-H]-; D-N-(Carboxyacetyl)alanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.049; RSYBGFZORPFBEV-SEFKMRKONA-N; [M-H]-; UNPD15404
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.990; QXAHNKVDGAGBNU-UHFFFAOYSA-N; [M-H]-; N-formylisoglutamic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.990; NVEYLYRWCRKVAU-UHFFFAOYSA-N; [M-H]-; 2-oxopropanoyl 2-aminopropaneperoxoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.848; SPJCNQDVYQSGSB-UHFFFAOYNA-N; [M-H]-; 3,4-dihydroxy-5-(2-hydroxyethanimidoyl)oxolan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; N-Acetyl-L-aspartic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.907; SPJCNQDVYQSGSB-UHFFFAOYNA-N; [M-H]-; 3,4-dihydroxy-5-(2-hydroxyethanimidoyl)oxolan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.874; AZKKNWAHCAZDCU-UHFFFAOYNA-N; [M-H]-; D-N-(Carboxyacetyl)alanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.851; HXWZRYKURKEOSO-UHFFFAOYNA-N; [M-H]-; 2-Amino-3-oxoadipate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.841; GIFXBNNGHVCVMF-UHFFFAOYSA-N; [M-H]-; 5-amino-2-hydroxy-2-methyl-1,3-dioxepane-4,7-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.827; ADZLWSMFHHHOBV-BYPYZUCNSA-N; [M-H]-; N-Formyl-L-glutamic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.820; QXAHNKVDGAGBNU-UHFFFAOYSA-N; [M-H]-; N-formylisoglutamic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.789; RSYBGFZORPFBEV-SEFKMRKONA-N; [M-H]-; UNPD15404
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.753; NVEYLYRWCRKVAU-UHFFFAOYSA-N; [M-H]-; 2-oxopropanoyl 2-aminopropaneperoxoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.723; BNJOZDZCRHCODO-UHFFFAOYSA-N; [M-H]-; dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; (2S)-2-acetamidobutanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.215; ADZLWSMFHHHOBV-BYPYZUCNSA-N; [M-H]-; (2S)-2-formamidopentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; AZKKNWAHCAZDCU-UHFFFAOYSA-N; [M-H]-; 3-(1-carboxyethylamino)-3-oxopropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; BNJOZDZCRHCODO-UHFFFAOYSA-N; [M-H]-; methyl 2-[(2-methoxy-2-oxoethyl)amino]-2-oxoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; HQESMQVYRAJTEA-UHFFFAOYSA-N; [M-H]-; 4-(carboxymethylamino)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.944; NWWNMEXBDCKKIG-JLAZNSOCSA-N; [M-H]-; (2R)-2-[(1S)-2-amino-1-hydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; JHLJBMKXTOOGCW-AIHAYLRMSA-N; [M-H]-; (3aS,5R,6R,6aR)-6-hydroxy-5-(hydroxymethyl)-3a,5,6,6a-tetrahydro-3H-furo[2,3-d][1,3]oxazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.788; VZRHBEPCALFDTQ-UHFFFAOYSA-N; [M-H]-; methyl 3-(methoxycarbonylamino)-3-oxopropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -1.718; OTCCIMWXFLJLIA; [M-H]-; bmse000423
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.969; AZKKNWAHCAZDCU; [M-H]-; 3-(1-carboxyethylamino)-3-oxopropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.655; QXAHNKVDGAGBNU; [M-H]-; 3-formamidopentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.393; ADZLWSMFHHHOBV; [M-H]-; formylglutamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.999; WRDWXTJVALMCAN; [M-H]-; N-(Vinyloxycarbonyl)-L-serine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.791; HXWZRYKURKEOSO; [M-H]-; 2-Amino-3-oxoadipate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.564; BNJOZDZCRHCODO; [M-H]-; dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -293.213; RSYBGFZORPFBEV; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -313.100; SPJCNQDVYQSGSB; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -328.855; NWWNMEXBDCKKIG; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.845; RTPBEMVDAXPYRC; [M-H]-; Scorbamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.911; OTCCIMWXFLJLIA; [M-H]-; bmse000423
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -22.289; OTCCIMWXFLJLIA; [M-H]-; Acetylaspartic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.070; AZKKNWAHCAZDCU; [M-H]-; 2-(2-carboxyacetamido)propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.660; XYNXPKJAVYJHOF; [M-H]-; 3-Acetylaspartic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -211.376; FOCKMBBVQYRNGP; [M-H]-; Propanedioic acid, (methoxyimino)-, dimethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -232.108; ZQWAVKINQMTJSS; [M-H]-; 3-[(Carboxycarbonyl)amino]butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -236.958; HXWZRYKURKEOSO; [M-H]-; 2-Amino-3-Oxoadipic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -239.095; WRDWXTJVALMCAN; [M-H]-; 2-(Ethenoxycarbonylamino)-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -240.732; HQESMQVYRAJTEA; [M-H]-; 4-(Carboxylatomethylamino)-4-oxobutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -241.421; QXAHNKVDGAGBNU; [M-H]-; N-formylisoglutamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -250.404; ISTWWSBLMQHYIQ; [M-H]-; N-oxalyl-alpha-methylalanine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.985; OTCCIMWXFLJLIA; [M-H]-; Acetylaspartic Acid
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match N-Acetyl-L-aspartic acid, OTCCIMWXFLJLIA-BYPYZUCNSA-N; Matching to 19 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000812;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C6H9NO5
CH$EXACT_MASS: 175.048072
CH$SMILES: CC(=O)N[C@@H](CC(=O)O)C(=O)O
CH$IUPAC: InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/t4-/m0/s1
CH$LINK: CHEBI CHEBI:16953
CH$LINK: HMDB HMDB0000812
CH$NAME: N-Acetyl-L-aspartate
CH$NAME: N-Acetyl-L-aspartate
CH$NAME: N-Acetyl-L-aspartic acid
CH$NAME: (2S)-2-acetamidobutanedioic acid
CH$LINK: INCHIKEY OTCCIMWXFLJLIA-BYPYZUCNSA-N
CH$LINK: PUBCHEM CID:65065
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.433
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 174.040213
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-052s-9400000000-09cfd26ca64bc91cf0a5
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0284390 359.8456 58.028414 0.5687 34.56 0.8951 12 ?
  59.0124395 172.2133 59.012415 0.8981 17.94 0.8741 12 ?
  70.0284124 32.3810 70.028394 1.0282 5.85 0.8273 11 ?
  71.0124374 80.1828 71.012419 0.5492 11.96 0.8811 12 ?
  88.0389644 999.0000 88.038962 0.6134 87.11 0.9091 12 ?
  96.9917215 34.1607 96.991730 1.3403 8.74 0.8182 12 ?
  97.9298829 51.3775 97.929893 0.6433 11.41 0.7182 11 ?
  99.9243866 798.5688 99.924399 0.5104 199.10 0.5385 12 ?
  100.9245126 59.2645 100.924527 0.7629 15.69 0.5035 12 ?
  112.0390379 48.1519 112.039070 1.0264 9.81 0.8392 12 ?
  114.0182835 133.1223 114.018319 0.4298 16.30 0.8909 11 ?
  114.9327647 16.5940 114.932802 0.9745 4.94 0.5879 10 ?
  115.0023443 99.3695 115.002382 0.7478 9.35 0.9510 12 ?
  115.9195142 23.4890 115.919553 0.8713 11.07 -0.2333 9 ?
  116.9271698 236.7497 116.927211 0.6585 61.68 0.5664 12 ?
  118.9650105 40.1325 118.965056 1.2104 13.28 -0.0182 11 ?
  129.8782552 24.9437 129.878323 1.1318 9.20 0.3818 10 ?
  130.0496893 143.0227 130.049757 0.4844 17.76 0.9161 12 f{C5H8N1O3}/-9.82ppm,p-C1O2
  146.9599909 69.7863 146.960101 1.2044 20.87 0.2587 12 ?
  156.0290266 35.0727 156.029162 1.1088 8.76 0.9030 10 f{C6H6N1O4}/-7.72ppm,p-H2O1
  174.0397509 115.4779 174.039943 0.9423 13.14 1.0000 12 f{C6H8N1O5}/-6.00ppm,p
  175.8611771 20.3027 175.861376 1.1316 4.97 0.6434 12 ?
  189.8505351 83.5556 189.850308 0.9270 26.36 0.5035 12 ?
  190.8485293 57.3019 190.848221 1.1737 12.79 0.6606 10 ?
PK$NUM_PEAK: 24
PK$PEAK: m/z int. rel.int.
  58.028439 359.85 359
  59.012439 172.21 172
  70.028412 32.38 32
  71.012437 80.18 80
  88.038964 999.00 999
  96.991722 34.16 34
  97.929883 51.38 51
  99.924387 798.57 798
  100.924513 59.26 59
  112.039038 48.15 48
  114.018283 133.12 133
  114.932765 16.59 16
  115.002344 99.37 99
  115.919514 23.49 23
  116.927170 236.75 236
  118.965011 40.13 40
  129.878255 24.94 24
  130.049689 143.02 143
  146.959991 69.79 69
  156.029027 35.07 35
  174.039751 115.48 115
  175.861177 20.30 20
  189.850535 83.56 83
  190.848529 57.30 57
//
